Logo
DCA

Repligen Corporation

RGENHealthcareMedical Instruments & Supplies
147,25 $US
-0.88%
Ultimo Prezzo
147,25 $US
2026-07-17
Variazione 24h
-0.88%
-1.30 USD
Volume
905.639
Azioni scambiate
Affidabilità Dati
Alta
10132 punti (40 anni)

Evoluzione del prezzo

Avvia una simulazione con questo asset

RGEN

Parametri globali

Dati disponibili dal 29/04/1986 al 17/07/2026

Analisi Fondamentale

New
CAGR (5y)
-2.70%
Revenue Growth
Net Margin
6.62%
Profitability
ROE
2.32%
Return on Equity
Debt / EBITDA
3.81
Solvency
PEG Ratio
2.08
Valuation vs Growth
Rev. Growth (TTM)
14.80%
Current Trend

Storico P/E (5 anni)

Historical PE
Average (137.1x)
Current: 145.1x
Focus tecnico
RGEN
Volatilità 30g
74.86%
Distanza da MA50
14.67%
Distanza da MA200
5.09%
Distanza da ATH
-54.58%
Momentum 3M
12.22%
Punteggio rischio
N/A

Volatilità moderata. Momentum neutro.

Su Repligen Corporation

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Investire in questo asset
Compra su Saxo Bank
🏦Broker regolamentato
🌍Accesso ai mercati globali
📈Strumenti Pro

Link pubblicitario. Capitale a rischio.

Analisi Tecnica e Rischio

Metriche Chiave

CAGR6.61%
Volatilità74.86%
Max Drawdown-50.64%

Momentum : RGEN

Indicateur synthétique
PEURNEUTREAVIDITÉ
52
Neutral

Analisi Rischio

VaR (95%)-6.45%
Salute DCA
61/100

Storia Recente (60 giorni)

DataChiusuraVolume
2026-07-17147,25 $US905.639
2026-07-16148,55 $US823.057
2026-07-15148,06 $US860.821
2026-07-14147,13 $US519.193
2026-07-13144,88 $US740.660
2026-07-10144,24 $US457.326
2026-07-09143,94 $US667.198
2026-07-08137,41 $US689.000
2026-07-07139,83 $US617.800
2026-07-06141,46 $US637.003
2026-07-02142,40 $US981.602
2026-07-01138,99 $US1.161.912
2026-06-30136,44 $US1.089.095
2026-06-29137,00 $US1.759.316
2026-06-26147,01 $US1.875.150
2026-06-25145,23 $US1.894.214
2026-06-24138,40 $US1.372.856
2026-06-23126,37 $US837.184
2026-06-22126,57 $US810.533
2026-06-18132,02 $US1.217.163
2026-06-17133,55 $US1.315.838
2026-06-16131,69 $US577.074
2026-06-15130,87 $US562.114
2026-06-12130,59 $US1.269.638
2026-06-11133,33 $US623.451
2026-06-10130,76 $US1.203.877
2026-06-09130,13 $US1.466.588
2026-06-08125,33 $US741.320
2026-06-05122,31 $US672.581
2026-06-04126,55 $US982.636
2026-06-03121,73 $US650.590
2026-06-02121,13 $US737.914
2026-06-01123,10 $US654.931
2026-05-29123,95 $US823.724
2026-05-28122,73 $US1.425.481
2026-05-27113,17 $US1.125.500
2026-05-26115,19 $US787.000
2026-05-22115,06 $US714.436
2026-05-21113,37 $US990.913
2026-05-20111,74 $US1.164.132
2026-05-19108,52 $US2.199.779
2026-05-18104,20 $US1.547.665
2026-05-15102,87 $US2.307.248
2026-05-14103,38 $US2.010.732
2026-05-13107,03 $US1.660.291
2026-05-12113,60 $US1.454.864
2026-05-11115,91 $US1.283.636
2026-05-08123,46 $US924.244
2026-05-07126,43 $US935.806
2026-05-06125,76 $US1.625.385
2026-05-05125,61 $US2.065.504
2026-05-04118,21 $US1.280.562
2026-05-01117,20 $US751.851
2026-04-30118,31 $US1.609.810
2026-04-29113,11 $US852.039
2026-04-28117,43 $US726.060
2026-04-27118,29 $US779.099
2026-04-24117,60 $US1.234.335
2026-04-23114,06 $US2.165.393
2026-04-22124,40 $US1.016.244

Asset Correlati